N@N

Market Maker Surveillance Report. LXRX, BTC, CVBK, MBR, VRX, DSTI, Winning Stocks With Lowest Price Friction For Thursday, Jan

^{Published on 2011-01-06 17:50:47 - WOPRAI}
 

January 6, 2011 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Thursday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Thursday there were 2739 companies with "abnormal" market making, 2076 companies with positive Friction Factors and 2943 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Thursday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. LEXICON PHARMACEUTICALS INC (NASDAQ:LXRX), COMMUNITY BANKERS TRUST CORP (AMEX:BTC), CENTRAL VIRGINIA BANKSHARES (NASDAQ:CVBK), MERCANTILE BANCORP -QUINCY (AMEX:MBR), VALEANT PHARMACEUTICALS INTE (NYSE:VRX), DAYSTAR TECHNOLOG (NASDAQ:DSTI). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

     Symbol     Change       Percent      Buy Volume      Buy %%       Sell Volume     Sell %%      Net Volume      Friction
     LXRX       $0.670       44.37%       10,395,694      50.44%       10,105,875      49.03%       289,819         4,326   
     BTC        $0.300       27.78%       183,340         68.52%       79,722          29.79%       103,618         3,454   
     CVBK       $1.100       91.67%       76,849          58.87%       51,122          39.16%       25,727          234     
     MBR        $0.450       45.00%       49,474          51.93%       25,570          26.84%       23,904          531     
     VRX        $5.750       19.20%       7,210,014       45.48%       6,237,209       39.34%       972,805         1,692   
     DSTI       $0.270       17.88%       448,783         52.72%       402,533         47.28%       46,250          1,713   

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net buy volumes (buy volume, sell volume) and low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows DSTI with a dollar gain Thursday of $0.27000 and a Friction Factor of 1,713 shares. That means that it only took 1,713 more shares of buying than selling to move DSTI higher by one penny. The Market Makers are currently allowing the stock to rise quickly (low friction). The combination of low friction and positive market direction can drive prices higher much faster than normal.

LEXICON PHARMACEUTICALS INC (NASDAQ:LXRX) - Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of human disease, including immunology, metabolism, cardiology, and ophthalmology. The companys drug candidates include LX1031, which has completed Phase II clinical trials for the treatment of irritable bowel syndrome and other gastrointestinal disorders; LX4211 that has completed Phase II clinical trials to treat type 2 diabetes; LX2931, which is in Phase II clinical trials for the treatment of rheumatoid arthritis and other autoimmune diseases; and LX1032 that has completed Phase II clinical trials to treat the symptoms associated with carcinoid syndrome. It also has a preclinical development drug candidate, LX7101, for the treatment of glaucoma. The company has drug discovery alliances with Bristol-Myers Squibb Company; Genentech, Inc.; N.V. Organon; and Takeda Pharmaceutical Company Limited. It also has drug development financing collaboration with Symphony Icon; collaboration agreement with Taconic Farms, Inc.; and an alliance with Nuevolution A/S, which provides access to Nuevolutions Chemetics platform chemistry technology. The company was founded in 1995 and is headquartered in The Woodlands, Texas.

COMMUNITY BANKERS TRUST CORP (AMEX:BTC) - Community Bankers Trust Corporation operates as the holding company for Bank of Essex that provides a range of financial services primarily to individuals and small businesses in Virginia, Maryland, and Georgia. Its deposit products include interest bearing demand deposit accounts, savings accounts, and time deposits. The companys loan portfolio comprises mortgage loans on real estate, including residential 1-4 family, commercial, construction, multifamily, and agriculture loans; commercial loans; consumer installment loans; and home equity loans. It also provides travelers checks, safe deposit box facilities, and fixed rate residential mortgages; sells title insurance to Bank of Essexs mortgage loan customers; and offers insurance and investment products. As of December 31, 2008, the company operated 24 full service banking facilities. Community Bankers Trust Corporation was founded in 1926 and is headquartered in Glen Allen, Virginia.

CENTRAL VIRGINIA BANKSHARES (NASDAQ:CVBK) - Central Virginia Bankshares, Inc. operates as the bank holding company for Central Virginia Bank, which provides community and commercial banking services to individuals and small to medium sized businesses. Its deposit products include checking accounts, savings deposits, interest bearing demand deposits, non-interest bearing demand deposits, money market accounts, certificates of deposits, and other time deposits. The companys loan portfolio comprises residential mortgage, commercial mortgage, real estate construction, and commercial business loans, as well as consumer loans, such as automobile loans, home equity lines of credit, and credit cards. It also provides Internet banking, telephone banking, debit cards, and other ancillary services, such as the sale of non-deposit investment products. In addition, the company offers ATMs, travelers checks, safe deposit boxes, deposit transfer, notary public, escrow, drive-in facilities, and other customary banking services. As of December 31, 2009, it operated seven branches in Powhatan, Chesterfield, Henrico, and Cumberland counties of Virginia. The company was founded in 1972 and is headquartered in Powhatan, Virginia.

MERCANTILE BANCORP -QUINCY (AMEX:MBR) - Mercantile Bancorp, Inc., a multi-state bank holding company, offers consumer and commercial banking, and trust services to the commercial, industrial, and agricultural areas in the United States. The companys deposit products include noninterest-bearing demand, interest-bearing demand, savings, negotiable order of withdrawal, checking, and time accounts, as well as transaction, money market, and time and brokered time deposits. It provides loans for commercial, financial, and agricultural purposes; consumer loans, including motor vehicle, watercraft, education, collateralized and non-collateralized personal, and deposit account collateralized loans; loans for real estate purposes, such as farmland, construction, and mortgages; commercial and residential real estate loans; and floor plan loans. The company offers asset management services, including trust, estate, and agency management; fiduciary services; retail brokerage services; agricultural business management services; and other customer services, such as safe deposit facilities. As of December 31, 2008, Mercantile Bancorp operated 28 banking facilities, including 26 full service offices, 1 stand-alone drive-up facility, and 1 loan production office serving 21 communities located throughout west-central Illinois, central Indiana, northern Missouri, eastern Kansas, and southwestern Florida. It also had six banks in its consolidated group; and minority interests in eight other banking organizations located in Missouri, Georgia, Tennessee, Florida, Colorado, and California. The company is headquartered in Quincy, Illinois.

VALEANT PHARMACEUTICALS INTE (NYSE:VRX) - Valeant Pharmaceuticals International, a specialty pharmaceutical company, engages in the development, manufacture, and marketing of a range of pharmaceutical products. It primarily offers specialty pharmaceutical and over-the-counter (OTC) products in the areas of dermatology and neurology therapeutic classes. The companys products include Efudex/Efudix for the treatment of multiple actinic or solar keratoses and superficial basal cell carcinoma; Acanya and Atralin gels for the treatment of acne vulgaris; Kinerase, a range of OTC and prescription cosmetic products; Nyal, a range of tablets, liquids, and nasal sprays to treat cough, cold, flu, sinus, and hayfever symptoms; and topical OTC products under the tradenames Dermaveen, Dr. LeWinns, and Dr. Renaud. It also offers Diastat/Diastat AcuDial, which are gel formulations of diazepam; Cesamet, a synthetic cannabinoid for the management of nausea and vomiting associated with cancer chemotherapy; Mestinon, an orally active cholinesterase inhibitor used in the treatment of myasthenia gravis; Migranal, a nasal spray formulation for the treatment of acute migraine headaches; and Librax, which is used as adjunctive therapy in the treatment of peptic ulcer and irritable bowel syndrome. In addition, the company provides branded generic products in antibiotics, antifungal medications, and diabetic therapies in Europe; and antibacterials, vitamin deficiency, and dermatology in Latin America. Valeant Pharmaceuticals has a license and collaboration agreement with Glaxo Group Limited to develop and commercialize retigabine, a neuronal potassium channel opener for the treatment of adult epilepsy patients with refractory partial onset seizures. It markets its products to physicians, hospitals, pharmacies, and wholesalers through its sales force, as well as through wholesalers primarily in the United States, Mexico, Poland, and Canada. The company was founded in 1960 and is headquartered in Aliso Viejo, California.

DAYSTAR TECHNOLOG (NASDAQ:DSTI) - DayStar Technologies, Inc. (DayStar) has developed a thin-film, copper-indium-gallium-selenide (CIGS) solar cell, for the direct conversion of sunlight into electricity (the photovoltaic (PV) effect). The Company's solar cell technology and manufacturing process is designed to use raw materials that do not suffer from the same supply constraints as silicon and use volume manufacturing equipment and procedures already proven in other industries, such as the magnetic disc drive industry. During the year ended December 31, 2004, the Company is in process of installing its first and second-generation batch and batch-continuous production lines at its Halfmoon, New York facility.

The Company's first-generation (Gen-I) production line employs batch processing and can be used for low-volume production and for production process development. In its second-generation (Gen-II) production line, DayStar is employing a combination of in-line continuous and batch-style production methodologies to produce working solar cells. In 2004, the Company qualified a majority of the components of each of these production lines. In February 2005, DayStar produced its first 100millimeter (mm) x 100mm solar cells using a combination of the Gen-I and Gen-II lines.

The third-generation manufacturing process (Gen-III) is characterized by a fully continuous manufacturing process. At this point, several components of the process previously accomplished in a batch fashion will then be integrated into the continuous pallet manufacturing equipment. The Company's fourth-generation manufacturing process (Gen-IV) will consist of conversion from a continuous pallet system to a continuous, roll-to-roll manufacturing process. In Gen-IV, pallets would be replaced by large rolls of substrate, such as metal foil, continuously fed through the manufacturing system using spools, and the various layers comprising the cell would be applied using a variety of thin-film deposition processes. The Company's full-scale, roll-to-roll system would be able to move large rolls of substrate material through the system. DayStar is also pursuing original equipment manufacturing (OEM) relationships with companies that will be interested in converting their existing manufacturing facilities to manufacture solar cells if the Company's manufacturing process is successful.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net